Intel Stock Jumps as TSMC Considers Foundry Stake With Nvidia and Other Chipmakers

Image source: Pexels

🚀 Intel Stock Jumps as TSMC Considers Foundry Stake With Nvidia and Other Chipmakers: Shares of Intel are jumping more than 7% in premarket trading Wednesday following a report that TSMC has approached U.S. chip designers Nvidia, Advanced Micro Devices, and Broadcom about forming a joint venture to own and run the chipmaker's foundry division. Yahoo Finance reports.

📉 February inflation report in focus as stagflation concerns grow: February's Consumer Price Index (CPI) will serve as the latest test of whether an inflation resurgence is a risk to the US economy as investors debate if and when the Federal Reserve will cut interest rates in 2025. The report, set for release at 8:30 a.m. ET on Wednesday, is expected to show price increases moderated during the second month of the year. Yahoo Finance reports.

📊 Markets extend losses as tariff uncertainty fuels volatility: U.S. stocks fell on Tuesday, adding to the biggest selloff in months, as investors worried about the impact of the latest tariff threats on the global economy. Trading was volatile, following conflicting tariff updates, while progress toward a ceasefire between Ukraine and Russia briefly lifted equities. Reuters reports.

👟 Puma shares sink to record low on weak growth outlook: Puma SE shares plunged the most on record after the sneaker maker disappointed investors with softer-than-expected results and forecast another year of slow growth. Yahoo Finance reports.

🎵 Spotify reports $10 billion in royalties paid amid legal battles: The company said its yearly payout to the music industry had risen 10 times from $1 billion in 2014. Spotify was hit with a lawsuit in U.S. that accused the company of underpaying songwriting royalties for tens of millions of songs last year. A federal judge in New York ruled to dismiss that suit this year. Reuters reports.

💊 Roche to develop $5.3B obesity drug in deal with Zealand Pharma: Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market. Reuters reports.

📉 Treasury yields edge lower as investors await inflation data: U.S. Treasury yields inched lower on Wednesday as investors keenly awaited the consumer inflation reading and monitored the latest tariff news. At 4:40 a.m. ET, the benchmark 10-year Treasury yield was over one basis point lower to 4.275%. The 2-year Treasury yield fell less than a basis point to 3.936%, after after falling to its lowest level since October on Tuesday morning. CNBC reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Benzinga reports.

1) $VSTE: Vast Renewables
Total gain: +94.27%

2) $HCTI: Healthcare Triangle
Total gain: +38.06%

3) $HTCO: High-Trend International
Total gain: +31.2%

4) $ANNA: AleAnna
Total gain: +30.01%

5) $BURU: Nuburu
Total gain: +23.99%

*Estimate and Actual numbers represent Earnings Per Share in US Dollars

ADBE: Adobe
1Q 2025
After Market Close
Estimate: 4.970
Actual: N/A

EH: EHang Holdings
4Q 2024
Before Market Open
Estimate: -0.070
Actual: N/A

MOMO: Hello Group
4Q 2024
After Market Close
Estimate: 0.210
Actual: N/A

Time (ET) / Report / Period

8:30 am - Consumer price index - Feb.
8:30 am - CPI year over year
8:30 am - Core CPI - Feb.

“The essence of investment management is to manage risk, not to manage returns.”

- Benjamin Graham

Sourced in: “The Intelligent Investor: The Definitive Book on Value Investing”, by Benjamin Grahamh, published in 1949.